Sustratos cromogénicos

Los sustratos cromogénicos son compuestos que producen un cambio de color visible cuando son metabolizados por enzimas específicas. Estos sustratos se utilizan ampliamente en ensayos diagnósticos, investigaciones bioquímicas y ensayos de inmunoabsorción enzimática (ELISA) para detectar y cuantificar la actividad enzimática. El cambio de color permite una identificación visual rápida y sencilla de las reacciones enzimáticas, lo que convierte a los sustratos cromogénicos en herramientas esenciales en el análisis de laboratorio. En CymitQuimica, ofrecemos una amplia selección de sustratos cromogénicos de alta calidad para apoyar sus aplicaciones de investigación y diagnóstico.

20
- 50
- 100
- 200

productos por página. Hay 790 productos en esta categoría.

Datos del producto	Pureza	Rango de precios	Entrega estimada
5-Bromo-4-chloro-3-indoxyl-α-L-fucopyranoside REF: 3D-B-7135CAS: 171869-92-4	Min. 98.0 Area-%	A consultar	Lun 16 Dic 24
5-Bromo-4-chloro-3-indoxyl-β-L-fucopyranoside REF: 3D-B-7138CAS: 125328-84-9	Min. 99 Area-%	A consultar	Lun 16 Dic 24
N-Acetyl-5-bromo-3-indoxyl-2,3,4-tri-O-acetyl-β-D-glucuronic acid methyl ester REF: 3D-A-0702	Min. 98.0 Area-%	A consultar	Lun 16 Dic 24
5-Bromo-4-chloro-3-indoxyl-β-D-cellobioside REF: 3D-B-7110CAS: 177966-52-8	Min. 99.0 Area-%	A consultar	Lun 16 Dic 24
Aldol® 535 myo-inositol-1-phosphate, ammonium salt, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4778_P00CAS: 2484872-80-0	Min. 95.0 Area-%	A consultar	Lun 16 Dic 24
Aldol® 515 caprylate solution, 0.50 M in DMSO, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4758_P00CAS: 2484873-04-1	Of Solute (Hplc) Min. 90.0 Area-%	A consultar	Lun 16 Dic 24
Aldol® 518 α-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4759_P00CAS: 2484873-05-2	Min. 95.0 Area-%	A consultar	Lun 16 Dic 24
Bronze-Gal REF: 3D-B-8935	- - -	A consultar	Lun 16 Dic 24
Aldol® 518 myo-inositol-1-phosphate, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4760_P00CAS: 2484873-07-4	Min. 95.0 Area-%	A consultar	Lun 16 Dic 24
Aldol® 470 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4679_P00CAS: 1254798-13-4	Min. 95.0 Area-%	A consultar	Lun 16 Dic 24
5-Bromo-4-chloro-3-indoxyl myo-inositol-1-phosphate, ammonium salt REF: 3D-B-7404CAS: 212515-11-2	Min. 90.0 Area-%	A consultar	Lun 16 Dic 24
Aldol® 518 β-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4734_P00CAS: 2484872-89-9	Min. 95.0 Area-%	A consultar	Lun 16 Dic 24
Aldol® 458 acetate, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4690_P00CAS: 2484872-51-5	Min. 95.0 Area-%	A consultar	Lun 16 Dic 24
Aldol® 470 nonanoate, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4683_P00CAS: 2484872-50-4	Min. 95.0 Area-%	A consultar	Lun 16 Dic 24
5-Bromo-4-chloro-3-indoxyl-3-acetate REF: 3D-B-6244CAS: 3252-36-6	Min. 98 Area-%	A consultar	Lun 16 Dic 24
5-Bromo-4-chloro-3-indoxyl-N-acetyl-β-D-glucosaminide REF: 3D-B-7000CAS: 4264-82-8	Min. 99.5 Area-%	A consultar	Lun 16 Dic 24
5-Bromo-4-chloro-3-indoxyl caprylate REF: 3D-B-7100CAS: 129541-42-0	Min. 99 Area-%	A consultar	Lun 16 Dic 24
Aldol® 518 β-D-glucuronic acid, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4735_P00CAS: 2484872-90-2	Min. 95 Area-%	A consultar	Lun 16 Dic 24
Aldol® 458 nonanoate, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4693_P00CAS: 2484872-52-6	Min. 98.0 Area-%	A consultar	Lun 16 Dic 24
5-Bromo-4-chloro-3-indoxyl sulfate, potassium salt REF: 3D-B-7600CAS: 6578-07-0	Min. 98.0 Area-%	A consultar	Lun 16 Dic 24

1g		A consultar
100mg		A consultar
250mg		A consultar
500mg		A consultar
2500mg		A consultar

10mg		A consultar
25mg		A consultar
50mg		A consultar
100mg		A consultar
250mg		A consultar

Sustratos cromogénicos

5-Bromo-4-chloro-3-indoxyl-α-L-fucopyranoside

Ref: 3D-B-7135

5-Bromo-4-chloro-3-indoxyl-β-L-fucopyranoside

Ref: 3D-B-7138

N-Acetyl-5-bromo-3-indoxyl-2,3,4-tri-O-acetyl-β-D-glucuronic acid methyl ester

Ref: 3D-A-0702

5-Bromo-4-chloro-3-indoxyl-β-D-cellobioside

Ref: 3D-B-7110

Aldol® 535 myo-inositol-1-phosphate, ammonium salt, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4778_P00

Aldol® 515 caprylate solution, 0.50 M in DMSO, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4758_P00

Aldol® 518 α-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4759_P00

Bronze-Gal

Ref: 3D-B-8935

Aldol® 518 myo-inositol-1-phosphate, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4760_P00

Aldol® 470 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4679_P00

5-Bromo-4-chloro-3-indoxyl myo-inositol-1-phosphate, ammonium salt

Ref: 3D-B-7404

Aldol® 518 β-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4734_P00

Aldol® 458 acetate, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4690_P00

Aldol® 470 nonanoate, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4683_P00

5-Bromo-4-chloro-3-indoxyl-3-acetate

Ref: 3D-B-6244

5-Bromo-4-chloro-3-indoxyl-N-acetyl-β-D-glucosaminide

Ref: 3D-B-7000

5-Bromo-4-chloro-3-indoxyl caprylate

Ref: 3D-B-7100

Aldol® 518 β-D-glucuronic acid, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4735_P00

Aldol® 458 nonanoate, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4693_P00

5-Bromo-4-chloro-3-indoxyl sulfate, potassium salt

Ref: 3D-B-7600